<!DOCTYPE html>
<html lang="zh-CN">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>智御 | AI肿瘤免疫药物自主设计平台 - 下一代智能药物研发系统</title>
    <meta name="description" content="智御平台致力于开发基于人工智能的下一代肿瘤免疫药物自主设计系统，聚焦PD1-IL2融合蛋白等创新药物研发。">
    <meta name="keywords" content="AI药物设计, 肿瘤免疫, PD1-IL2, 人工智能, 深度学习, 药物研发, 生物信息学">
    <meta name="author" content="智御 AI Drug Design Platform">
    <meta name="robots" content="index, follow">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="website">
    <meta property="og:title" content="智御 | AI肿瘤免疫药物自主设计平台">
    <meta property="og:description" content="融合人工智能与生物学前沿技术，重新定义肿瘤免疫药物研发的未来">
    <meta property="og:locale" content="zh_CN">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:title" content="智御 | AI肿瘤免疫药物自主设计平台">
    <meta property="twitter:description" content="融合人工智能与生物学前沿技术，重新定义肿瘤免疫药物研发的未来">

    <!-- Canonical Link -->
    <link rel="canonical" href="https://intelligentbattery.com/index.html">

    <!-- Structured Data -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "name": "智御",
      "alternateName": "AI肿瘤免疫药物自主设计平台",
      "description": "基于人工智能的下一代肿瘤免疫药物自主设计系统，聚焦PD1-IL2融合蛋白等创新药物研发",
      "url": "https://intelligentbattery.com",
      "logo": "https://intelligentbattery.com/favicon.svg",
      "sameAs": [
        "https://gitee.com/baiyuan1/intellgentbattery_webpage"
      ],
      "contactPoint": {
        "@type": "ContactPoint",
        "contactType": "recruitment",
        "email": "hr@intelligentbattery.com"
      }
    }
    </script>

    <link rel="icon" type="image/svg+xml" href="favicon.svg">
    <link rel="stylesheet" href="css/style.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link rel="preload" href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;700;800&display=swap" as="style">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;700;800&display=swap" rel="stylesheet">
</head>

<body>

    <!-- Navigation -->
    <nav class="navbar">
        <div class="logo">智御 AI Drug Design</div>
        <button class="hamburger" aria-label="Toggle navigation" aria-expanded="false" aria-controls="primary-navigation">
            <span></span>
            <span></span>
            <span></span>
        </button>
        <ul class="nav-links" id="primary-navigation">
            <li><a href="index.html" class="active" data-i18n="nav.home">首页</a></li>
            <li><a href="team.html" data-i18n="nav.team">团队介绍</a></li>
            <li><a href="news.html" data-i18n="nav.news">动态与成果</a></li>
            <li><a href="recruit.html" data-i18n="nav.recruit">加入我们</a></li>
        </ul>
        <div class="lang-switcher">
            <button class="lang-btn active" data-lang="zh" aria-label="Switch to Chinese">中文</button>
            <button class="lang-btn" data-lang="en" aria-label="Switch to English">EN</button>
        </div>
    </nav>

    <!-- Hero Section -->
    <header class="hero">
        <div class="hero-content">
            <h1 data-i18n="hero.index_title">智御<br><span data-i18n="hero.index_subtitle">AI肿瘤免疫药物自主设计平台</span></h1>
            <p data-i18n="hero.index_description">融合人工智能与生物学前沿技术，重新定义肿瘤免疫药物研发的未来。</p>
            <a href="#intro" class="btn btn-primary">
                <span data-i18n="hero.learn_more">了解更多</span>
                <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                    stroke-linejoin="round">
                    <line x1="12" y1="5" x2="12" y2="19"></line>
                    <polyline points="19 12 12 19 5 12"></polyline>
                </svg>
            </a>
        </div>
    </header>

    <!-- Introduction Section -->
    <section id="intro">
        <div class="container">
            <h2 class="section-title"><span data-i18n="sections.intro">项目介绍</span></h2>

            <div class="grid-container">
                <div class="card expand-trigger" tabindex="0" role="button" aria-expanded="false">
                    <div class="card-icon">
                        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-linecap="round"
                            stroke-linejoin="round">
                            <circle cx="12" cy="12" r="10"></circle>
                            <line x1="12" y1="16" x2="12" y2="12"></line>
                            <line x1="12" y1="8" x2="12.01" y2="8"></line>
                        </svg>
                    </div>
                    <h3><span data-i18n="cards.background_title">管线特色</span> <span class="interactive-badge" data-i18n="interactive.expand">点击展开</span></h3>
                    <p data-i18n="cards.background_desc">PD1-IL2是汇聚前沿生物学洞见与转化潜力的关键靶点，其开发不仅具备严谨的科学依据与千亿规模的市场，更承载着肿瘤免疫治疗下一阶段突破的重要使命。</p>
                    <div class="expandable-content">
                        <div class="expandable-wrapper">
                            <h4 class="text-primary mb-1" data-i18n="cards.background_ch1_title">生物侧评估结果：</h4>
                            <ul class="lh-1-8 text-muted">
                                <li>• 可表达性：成功率超过40%，成功表达了40多条IL2单体</li>
                                <li>• 受体结合：可与超过80%受体α、β、γ、βγ结合</li>
                                <li>• 符合开发标准的单体超过30条，挑选16个进行细胞实验</li>
                                <li>• PBMC pSTAT5实验挑选出4个候选蛋白：0008、0042、0059、0085</li>
                                <li>• 4个候选蛋白表达纯化良好，瞬转表达量150-500mg/L，纯度超过90%</li>
                                <li>• 0042的MC38动物实验结果良好，B16F10实验进行中</li>
                            </ul>
                            <h4 class="text-primary mt-2 mb-1" data-i18n="cards.background_ch2_title">平台潜力：</h4>
                            <p class="text-muted" data-i18n="cards.background_ch2_text">IL2作为连接抗体与多肽的关键细胞因子，其深入研究将同步推动两类治疗模式的平台化发展。相关研究可以泛化到抗体的VHH、VL、VH设计与优化，具有很好的产业转化潜力。
                            </p>
                        </div>
                    </div>
                </div>
                <div class="card expand-trigger" tabindex="0" role="button" aria-expanded="false">
                    <div class="card-icon">
                        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-linecap="round"
                            stroke-linejoin="round">
                            <polygon points="12 2 2 7 12 12 22 7 12 2"></polygon>
                            <polyline points="2 17 12 22 22 17"></polyline>
                            <polyline points="2 12 12 17 22 12"></polyline>
                        </svg>
                    </div>
                    <h3><span data-i18n="cards.research_title">AI特色 - 模块化</span> <span class="interactive-badge" data-i18n="interactive.expand">点击展开</span></h3>
                    <p data-i18n="cards.research_desc">AI药物研发系统分为四个层面：临床市场信息层、AI自主立项层、数字实验室层、实验智能管理层，实现全流程智能化。</p>
                    <div class="expandable-content">
                        <div class="expandable-wrapper">
                            <h4 class="text-primary mb-1" data-i18n="cards.research_ch1_title">智能信息引擎：</h4>
                            <ul class="lh-1-8 text-muted">
                                <li>• 聚合商业信息平台、社媒平台、会议平台等多源信息</li>
                                <li>• 每天推荐最新的极具潜力的靶点和药物</li>
                                <li>• 辅助AI自主立项决策</li>
                                <li>• 成熟靶点的新组合挖掘以及高通量实验验证</li>
                            </ul>
                            <h4 class="text-primary mt-2 mb-1" data-i18n="cards.research_ch2_title">系统优势：</h4>
                            <p class="text-muted" data-i18n="cards.research_ch2_text">通过模块化设计，实现从信息收集到实验验证的全流程自动化，显著提升药物研发效率和成功率。</p>
                        </div>
                    </div>
                </div>
                <div class="card expand-trigger" tabindex="0" role="button" aria-expanded="false">
                    <div class="card-icon">
                        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-linecap="round"
                            stroke-linejoin="round">
                            <polyline points="22 12 18 12 15 21 9 3 6 12 2 12"></polyline>
                        </svg>
                    </div>
                    <h3><span data-i18n="cards.content_title">AI特色 - 多目标优化与可控性</span> <span class="interactive-badge" data-i18n="interactive.expand">点击展开</span></h3>
                    <p data-i18n="cards.content_desc">通过多目标强化学习优化和领域知识约束，实现从黑盒最优到可控权衡的智能药物设计。</p>
                    <div class="expandable-content">
                        <div class="expandable-wrapper">
                            <h4 class="text-primary mb-1" data-i18n="cards.content_ch1_title">多目标优化：</h4>
                            <ul class="lh-1-8 text-muted">
                                <li>• <strong>目标分解</strong>：亲和力、免疫原性、稳定性等作为目标集合，权重可调</li>
                                <li>• <strong>强化学习</strong>：ZMutation算法进行Pareto/权重优化</li>
                                <li>• <strong>实验对齐</strong>：湿实验多受体结合等readout作为反馈信号</li>
                                <li>• <strong>高命中率</strong>：结合命中率接近100%，多受体结合读出30+/30+</li>
                            </ul>
                            <h4 class="text-primary mt-2 mb-1" data-i18n="cards.content_ch2_title">可控性保障：</h4>
                            <p class="text-muted" data-i18n="cards.content_ch2_text">数据冷启动流水线（LLM+Agent）实现收集-筛选-分析-预标注闭环，领域知识约束显式化，干湿闭环校准持续优化，跨文献/机制/靶点覆盖提升泛化性。</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- FAQ Section -->
    <section class="bg-transparent">
        <div class="container">
            <h2 class="section-title"><span data-i18n="sections.faq">常见问题</span></h2>
            <div class="max-w-800 mx-auto">
                <div class="faq-item">
                    <div class="faq-question" tabindex="0" role="button" aria-expanded="false">
                        <span data-i18n="faq.q1">什么是PD1-IL2融合蛋白？</span>
                        <span class="icon">+</span>
                    </div>
                    <div class="faq-answer">
                        <p class="text-muted lh-1-8" data-i18n="faq.a1">
                            PD1-IL2融合蛋白是一种创新的肿瘤免疫治疗药物，将PD1抗体与IL2细胞因子融合，既能阻断肿瘤免疫逃逸，又能激活免疫细胞。IL2作为连接抗体与多肽的关键细胞因子，其研究将推动多种免疫治疗模式的发展。
                        </p>
                    </div>
                </div>
                <div class="faq-item">
                    <div class="faq-question" tabindex="0" role="button" aria-expanded="false">
                        <span data-i18n="faq.q2">平台的AI设计流程是怎样的？</span>
                        <span class="icon">+</span>
                    </div>
                    <div class="faq-answer">
                        <p class="text-muted lh-1-8" data-i18n="faq.a2">
                            平台采用模块化设计：<strong>临床信息层</strong>负责市场与靶点信息收集；<strong>AI立项层</strong>进行智能决策；<strong>数字实验室层</strong>进行序列设计与优化，通过多目标强化学习实现亲和力、稳定性等多维度优化；<strong>实验管理层</strong>实现干湿闭环反馈，持续提升预测准确性。
                        </p>
                    </div>
                </div>
                <div class="faq-item">
                    <div class="faq-question" tabindex="0" role="button" aria-expanded="false">
                        <span data-i18n="faq.q3">相比传统药物研发，AI平台有什么优势？</span>
                        <span class="icon">+</span>
                    </div>
                    <div class="faq-answer">
                        <p class="text-muted lh-1-8" data-i18n="faq.a3">
                            传统药物研发采用试错法，周期长成本高。我们的AI平台通过多目标优化，实现可表达性超过40%，受体结合命中率接近100%。平台具备数据冷启动能力，可在文献数据不足时自主生成训练数据。跨文献/机制/靶点的多层次建模支撑多路径探索，显著缩短研发周期，降低研发成本。
                            </p>
                    </div>
                </div>
                <div class="faq-item">
                    <div class="faq-question" tabindex="0" role="button" aria-expanded="false">
                        <span data-i18n="faq.q4">项目的应用前景如何？</span>
                        <span class="icon">+</span>
                    </div>
                    <div class="faq-answer">
                        <p class="text-muted lh-1-8" data-i18n="faq.a4">
                            项目聚焦PD1-IL2融合蛋白等肿瘤免疫药物，具备千亿规模市场潜力。平台技术高度可拓展，可快速迁移至抗体VHH、VL、VH设计与优化等领域。目前已获得4个不同活性IL2候选蛋白，初步具备PCC分子潜力，动物实验结果良好。平台的产业转化潜力显著，有望在肿瘤免疫治疗领域实现突破。</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="footer-content">
            <div class="footer-links">
                <a href="https://gitee.com/baiyuan1/intellgentbattery_webpage" target="_blank" rel="noopener noreferrer">
                    <svg viewBox="0 0 24 24" width="18" height="18" stroke="currentColor" fill="none" stroke-width="2"
                        stroke-linecap="round" stroke-linejoin="round">
                        <path
                            d="M9 19c-5 1.5-5-2.5-7-3m14 6v-3.87a3.37 3.37 0 0 0-.94-2.61c3.14-.35 6.44-1.54 6.44-7A5.44 5.44 0 0 0 20 4.77 5.07 5.07 0 0 0 19.91 1S18.73.65 16 2.48a13.38 13.38 0 0 0-7 0C6.27.65 5.09 1 5.09 1A5.07 5.07 0 0 0 5 4.77a5.44 5.44 0 0 0-1.5 3.78c0 5.42 3.3 6.61 6.44 7A3.37 3.37 0 0 0 9 18.13V22">
                        </path>
                    </svg>
                    <span data-i18n="footer.repo">Gitee仓库</span>
                </a>
                <a href="mailto:contact@zhiyu-ai.com">
                    <svg viewBox="0 0 24 24" width="18" height="18" stroke="currentColor" fill="none" stroke-width="2"
                        stroke-linecap="round" stroke-linejoin="round">
                        <path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"></path>
                        <polyline points="22,6 12,13 2,6"></polyline>
                    </svg>
                    <span data-i18n="footer.contact">联系我们</span>
                </a>
            </div>
            <p data-i18n="footer.copyright">&copy; 2026 智御 AI Drug Design Platform. All Rights Reserved.</p>
        </div>
    </footer>

    <!-- Image Lightbox -->
    <div class="lightbox" role="dialog" aria-label="Image lightbox" aria-hidden="true">
        <button class="lightbox-close" aria-label="Close lightbox">&times;</button>
        <img src="" alt="Enlarged view" class="lightbox-img">
    </div>

    <!-- Back to Top Button -->
    <button class="back-to-top" aria-label="Back to top">
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
            stroke-linejoin="round">
            <polyline points="18 15 12 9 6 15"></polyline>
        </svg>
    </button>

    <script src="js/i18n.js"></script>
    <script src="js/main.js"></script>
</body>

</html>